
1. j immunol. 2009 jul 15;183(2):1229-37. doi: 10.4049/jimmunol.0802145. epub 2009
jun 24.

significance n-terminal proteolysis ccl14a activity chemokine
receptors ccr1 ccr5 human cytomegalovirus-encoded chemokine receptor 
us28.

richter r(1), casarosa p, ständker l, münch j, springael jy, nijmeijer s,
forssmann wg, vischer hf, vakili j, detheux m, parmentier m, leurs r, smit mj.

author information: 
(1)institute transfusion medicine immune hematology, blood donation
service german red cross, frankfurt, germany. rudorichter@gmx.de

the cc chemokine ccl14a constitutively expressed large variety tissues
and inactive proform ccl14a(1-74) circulates high concentrations in
plasma. ccl14a(1-74) converted ccl14a(9-74) proteases
urokinase-type plasminogen activator plasmin highly active agonist
for chemokine receptors ccr1 ccr5. study, new ccl14a analog,
ccl14a(12-74), isolated blood filtrate. elucidate functional role
of n terminus, panel n-terminally truncated ccl14a analogs tested
on receptors ccr1 ccr5 human cytomegalovirus (hcmv)-encoded
chemokine receptor us28. rank order binding affinity receptors
and activation ccr1 ccr5-mediated intracellular ca(2+)
concentration mobilization ccl14a(6-74)<(7-74)<(8-74)<<(9-74) =
(10-74)>>(11-74)>>(12-74). almost identical affinities ccl14a(7-74),
ccl14a(9-74), ccl14a(10-74) us28 receptor inhibition of
us28-mediated hiv infection 293t cells n-terminally truncated
ccl14a analogs support promiscuous nature viral chemokine receptor
us28. high concentrations, ccl14a(12-74) reveal antagonistic activity on
intracellular ca(2+) concentration mobilization ccr1- ccr5-transfected
cells, suggests truncation tyr(11) might significance 
efficient inactivation ccl14a. putative inactivation pathway ccl14a(9-74)
to ccl14a(12-74) may involve dipeptidase cd26/dipeptidyl peptidase iv
(dppiv), generates ccl14a(11-74), metalloprotease aminopeptidase n 
(cd13), displays capacity generate ccl14a(12-74) ccl14a(11-74).
our results suggest activity ccl14a might regulated stringent
proteolytic activation inactivation steps.

doi: 10.4049/jimmunol.0802145 
pmid: 19553544  [indexed medline]

